# Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients

> **NCT03048760** · NA · COMPLETED · sponsor: **The Christie NHS Foundation Trust** · enrollment: 30 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** MRI scan

## Key facts

- **NCT ID:** NCT03048760
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-11
- **Primary completion:** 2019-01-21
- **Final completion:** 2019-01-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03048760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03048760, "Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03048760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*